Company / Cash per Share
Tvardi Therapeutics, Inc. Cash per Share History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$8.35
FY2024
5-year range
$0.27 / $8.35
FY2020-FY2024
Trend
+767.5%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Cash per Share changed +767% YoY in FY2024, a notable deviation from the 9-year average annual change of +143%.
Based on SEC 10-K filings.
8.35 in FY2024 with a 5-year CAGR of +78.3%.
Improved from $1.19 to $8.35 over the past 2 years.
Cash per Share over time
Growth rates
- 3-Year CAGR
- +214.0%
- 5-Year CAGR
- +78.3%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2024, cash per share increased 767.5% year-over-year.
- Lowest cash per share in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score -6.41 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $8.35 | +767.5% |
| FY2023 | $0.96 | -19.3% |
| FY2022 | $1.19 | +341.8% |
| FY2021 | $0.27 | -60.2% |
| FY2020 | $0.68 | +46.5% |
| FY2019 | $0.46 | +0.2% |
| FY2018 | $0.46 | +34.3% |
| FY2017 | $0.34 | -82.2% |
| FY2016 | $1.93 | +256.6% |
| FY2015 | $0.54 | +108.0% |
As of FY2024 · SEC 10-K · Updated Jun 28, 2026